BMO Capital analyst Michael Zaremski maintained a Buy rating on Allstate yesterday and set a price target of $235.00.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Michael Zaremski has given his Buy rating due to a combination of factors including Allstate’s recent performance and future growth prospects. The company has shown a significant improvement in its earnings per share estimates for the upcoming years, driven by a better-than-expected second quarter and a reduced expense ratio. Although there are concerns about near-term buybacks and a slightly higher underlying loss ratio, these are offset by the company’s bullish comments on auto organic growth.
Despite potential challenges in the third quarter, such as the need for improved retention rates, the long-term outlook remains positive. The transition of Esurance’s California policies to NatGen and the profitability of the remaining Esurance book suggest that related attrition will likely slow down. Additionally, Allstate’s strategic moves in the New York and New Jersey markets, along with the anticipated fading of drag from legacy brands by 2026, support a positive trajectory for organic policy count growth. These factors contribute to an increased price target and a Buy recommendation.
Zaremski covers the Financial sector, focusing on stocks such as Brown & Brown, Progressive, and Travelers Companies. According to TipRanks, Zaremski has an average return of 9.2% and a 66.85% success rate on recommended stocks.
In another report released yesterday, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $240.00 price target.